Cat. No. | Product name | CAS No. |
DCC4902 |
Ssm3 Tfa Salt
Potent furin inhibitor, blocking furin-dependent cell surface processing of anthrax protective antigen-83 in vitro. |
922732-52-3 |
DCC4903 |
SS-nf-atra
Novel chimeric degrader against cellular retinoic acid binding proteins (CRABPs), inducing the AhR-dependent degradation of CRABP-1 and CRABP-2 via the ubiquitin-proteasome pathway |
|
DCC4904 |
SS-nf-jq1
Novel chimeric degrader against bromodomain-containing (BRD) proteins, inducing the interaction of AhR and BRD proteins and displaying effective anticancer activity that correlated with protein knockdown activity |
|
DCC4905 |
SS-nicotinamide Adenine Dinucleotide, Reduced Disodium
Cofactor for mitochondrial deacetylase sirtuin-3 enzyme, regulating energy metabolism and immunity and modulating inflammasome assembly |
606-68-8 |
DCC4906 |
Ssr126768a
Novel Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor |
785048-28-4 |
DCC4907 |
Ssr180575
Featured
SSR-180,575 is a drug which acts as a selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO. It has been shown to have neuroprotective and cardioprotective effects and to stimulate steroidogenesis of pregnenolone in the brain, which may be linked to its neuroprotective action. |
220448-02-2 |
DCC4908 |
SS-thujaplicinol
Inhibitor of the replication of herpes simplex viruses 1 and 2 (HSV-1 and HSV-2) |
4356-35-8 |
DCC4909 |
Sstr3-agonist-5c
Novel non-peptidic highly potent somatostatin receptor 3 (SSTR3) agonist |
|
DCC4910 |
Sstr3-antagonist-3a
Novel potent sstr3 antagonist, showing to reduce glucose excursion in a mouse oGTT assay |
|
DCC4911 |
Sstr5a
Novel somatostatin receptor subtype 5 antagonist, stimulating glucoseinduced GLP-1 secretion, reducing blood glucose in a gut- and GLP-1R-dependent manner |
|
DCC4912 |
St026567
Novel potent mast cell (MC) activator, promoting de novo synthesis of cytokines and inducing the release of eicosanoids from human and mouse MCs |
5067-25-4 |
DCC4913 |
St029248
Novel potent mast cell (MC) activator, promoting de novo synthesis of cytokines and inducing the release of eicosanoids from human and mouse MCs |
96-69-5 |
DCC4914 |
St056083
Novel inhibitor of the c-di-AMP synthetase DNA integrity scanning protein (DisA) in vitro |
299419-24-2 |
DCC4915 |
St101036
Novel potent mast cell (MC) activator, promoting de novo synthesis of cytokines and inducing the release of eicosanoids from human and mouse MCs |
1018143-39-9 |
DCC4916 |
st-1032
Novel histamine H3 receptor ligand |
|
DCC4917 |
St1237
Potent, direct, non-cytotoxic Arachidonate_5-lipoxygenase>5-lipoxygenase (5-LO) inhibitor |
1380593-17-8 |
DCC4918 |
St-161
Antiviral agent against LASV and a number of other viruses in the Arenaviridae family |
|
DCC4919 |
St-1703
Novel histamine H3 receptor ligand |
|
DCC4920 |
St-1892
Novel highly potent and soluble partial FXR agonist |
1409411-32-0 |
DCC4921 |
St-198
Seletive dopamine D3 receptors |
854924-64-4 |
DCC4922 |
St-1992
Novel potent A 1 R/A 2A R/H 3 R multitargeting ligand (MTL) |
|
DCC4923 |
St-2001
Novel potent A 1 R/A 2A R/H 3 R multitargeting ligand (MTL) |